Macclesfield, United Kingdom

Emma Jane Williams



Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 189(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emma Jane Williams: Innovator in Antineoplastic Agents

Introduction

Emma Jane Williams is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antineoplastic agents. With a total of 3 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are the innovative compounds described as 2,4-DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines. These compounds are recognized for their potential as antineoplastic agents. The patents detail pyrimidine derivatives of formula (I), wherein Q, Q, G, and R are defined within the documents. Additionally, the patents cover pharmaceutically acceptable salts and in vivo hydrolysable esters of these compounds. The processes for their manufacture, pharmaceutical compositions, and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.

Career Highlights

Emma Jane Williams is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Throughout her career, Emma has collaborated with notable colleagues, including Elizabeth Janet Pease and Robert Hugh Bradbury. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Emma Jane Williams stands out as a key figure in the development of antineoplastic agents, with her innovative patents paving the way for future advancements in cancer treatment. Her contributions to AstraZeneca and collaborations with esteemed colleagues further highlight her impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…